Substantial effort has been made over the last six decades to identify biomarkers for multiple
sclerosis that can improve disease diagnosis, predict disease progression, and improve …

In recent years, microRNAs (miRNAs) have gained increased attention from researchers
around the globe. Although it is twenty nucleotides long, it can modulate several gene …

For many neurological diseases, the efficacy and outcome of treatment depend on early
detection. Diagnosis is currently based on the detection of symptoms and neuroimaging …

Background Parkinson's disease (PD) is the most common movement disorder among
adults, affecting 2% of the world population older than 65 years of age. No diagnostic …

Introduction: Advances in molecular pathogenesis suggest that the chronic inflammation is a
shared mechanism in the initiation and progression of multiple neurodegenerative diseases …

Many neurodegenerative diseases, such as Alzheimer's disease, Parkinson disease,
vascular and frontotemporal dementias, as well as other chronic neurological pathologies …

Multiple sclerosis (MS) is a chronic autoimmune disease that impacts the central nervous
system and can result in disability. Although the prevalence of MS has increased in India …

Multiple sclerosis (MS) is a leading cause of progressive disability among young adults
caused by inflammation, demyelination and axonal loss in the central nervous system. Small …

MicroRNAs (miRNAs) are small non-coding RNA molecules acting as post-transcriptional
regulators of gene expression. They are involved in many biological processes, and their …

Transforming growth factor beta (TGF‐β) is a pleiotropic cytokine that has been shown to
influence the differentiation and function of T cells. The role that TGF‐β plays in immune …